StratCare-2 is a clinical trial evaluating the clinical and cost-effectiveness of AI-driven stratified care for depression.
StratCare-2 is a clinical trial evaluating the clinical and cost-effectiveness of AI-driven stratified care for depression.
Embedded Files
Important message for participants:
Many of you will now be receiving the 12 month follow up questionnaire booklet. This will be sent via the contact method that you specified when you joined the study. This questionnaire is very important for our research and is vital for us to understand how best to help people with depression.
If you have any concerns, or would like to receive your questionnaires via a different method of contact, please email the study team: stratcare-2_trial@sheffield.ac.uk.
The study is being led and managed by the Clinical Trials Research Unit at the University of Sheffield. CTRU webpage for StratCare-2
This study is funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme.
All research in the NHS is overseen by an independent group of people, a Research Ethics Committee, to protect your safety, rights, wellbeing and dignity. This trial has been reviewed and approved by the London - Sussex and Brighton REC (Ref: 24/LO/0576, approved on 18/09/2024).
Page updated
Report abuse